RenDx Multiplex Assay System
Providing rapid, sensitive, multiplex diagnostics of infectious disease.
Using patented technology based on surface enhanced resonance Raman scattering (SERRS), Renishaw has developed the RenDx Multiplex Assay System to provide automated, multiplex, high sensitivity in vitro diagnosis of infectious disease.
Based on a multiplex PCR approach, the system offers several advantages over traditional diagnostic methods.
- Multiplex PCR technology - Fungiplex assay detects up to 10 targets from a single sample.
- High sensitivity detection - single organism detection
- High throughput - up to 92 samples/controls per run
- Fast processing times - results within hours
Find out more about RenDx assay technology
RD025-02 RenDx Fungiplex Brochure
Find out how Renishaw is revolutionising diagnosis of invasive fungal disease.
Assay development pipeline
Our team is currently developing assays that will detect the most common causes of bacterial gastroenteritis and the most prevalent families of antibiotic resistance genes.
The RenDx SP-2000 Sample Processor is a purpose-built instrument that, together with the SA-2000 Sample Analyser, forms the RenDx Multiplex Assay System.